7.Minot G R. Studies on a case of idiopathic purpura hemorrhagica[J]. The American Journal of the Medical Sciences (1827-1924), 1916, 152(1): 48.
8.Brecher G, Cronkite E P. Morphology and enumeration of human blood platelets[J]. Journal of Applied Physiology, 1950, 3(6): 365-377.
9.Brecher G, Schneiderman M, Cronkite E P. The reproducibility and constancy of the platelet count[J]. American Journal of Clinical Pathology, 1953, 23(1): 15-26.
10.Sloan A W. The normal platelet count in man[J]. Journal of clinical pathology, 1951, 4(1): 37.
11.Kelemen E, Cserhati I, Tanos B. Demonstration and some properties of human thrombopoietin in thrombocythaemic sera[J]. Acta haematologica, 1958, 20(6): 350-355.
12.Kuter D J. Milestones in understanding platelet production: a historical overview[J]. British journal of haematology, 2014, 165(2): 248-258.
13.Li J, Yang C, Xia Y, et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin[J]. Blood, 2001, 98(12): 3241-3248.
14.Makar R S, Zhukov O S, Sahud M A, et al. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists[J]. American journal of hematology, 2013, 88(12): 1041-1044.
15.Carver-Moore K, Broxmeyer H E, Luoh S M, et al. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice[J]. Blood, 1996, 88(3): 803-808.
16.Souyri M, Vigon I, Penciolelli J F, et al. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors[J]. Cell, 1990, 63(6): 1137-1147.
17.Vigon I, Mornon J P, Cocault L, et al. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily[J]. Proceedings of the National Academy of Sciences, 1992, 89(12): 5640-5644.
18.Wendling F, Tambourin P. The oncogene V-MPL, a putative truncated cytokine receptor which immortalizes hematopoietic progenitors[J]. Nouvelle revue francaise d'hematologie, 1991, 33(2): 145.
19.Bartley T D, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI[J]. Cell, 1994, 77(7): 1117-1124.
20.De Sauvage F J, Hass P E, Spencer S D, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand[J]. Nature, 1994, 369(6481): 533.
21.Kuter D J, Beeler D L, Rosenberg R D. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production[J]. Proceedings of the National Academy of Sciences, 1994, 91(23): 11104-11108.
22.Wörmann B. Clinical indications for thrombopoietin and thrombopoietin-receptor agonists[J]. Transfusion Medicine and Hemotherapy, 2013, 40(5): 319-325.
23.Kuter D J, Begley C G. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies[J]. Blood, 2002, 100(10): 3457-3469.
24.Goodnough L T, Kuter D J, McCullough J, et al. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin[J]. Blood, 2001, 98(5): 1346-1351.
25.Vadhan-Raj S, Kavanagh J J, Freedman R S, et al. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study[J]. The Lancet, 2002, 359(9324): 2145-2152.
26.Vadhan-Raj S, Murray L J, Bueso-Ramos C, et al. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer[J]. Annals of internal medicine, 1997, 126(9): 673-681.
27.Kong Z, Qin P, Xiao S, et al. A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy[J]. Blood, 2017: blood-2017-01-761262.
28.Siemensma N P, Bathal P S, Penington D G. The effect of massive liver resection on platelet kinetics in the rat[J]. The Journal of laboratory and clinical medicine, 1975, 86(5): 817-833.
29.Novotny V M J. Prevention and management of platelet transfusion refractoriness[J]. Vox sanguinis, 1999, 76(1): 1-13.
本文作者 | 苑臘靜
閱讀更多 奇點網 的文章
